MedPath

Sodium Fluoride

These highlights do not include all the information needed to use SODIUM FLUORIDE F 18 INJECTION safely and effectively. See full prescribing information for SODIUM FLUORIDE F 18 INJECTION. SODIUM FLUORIDE F 18 INJECTION For Intravenous Use Initial U.S. Approval:

Approved
Approval ID

ef58c3cd-a922-c5fc-e053-2a95a90a9d74

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 29, 2023

Manufacturers
FDA

BAMF Health Inc.

DUNS: 117208762

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

SODIUM FLUORIDE F-18

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code81759-002
Application NumberANDA204328
Product Classification
M
Marketing Category
C73584
G
Generic Name
SODIUM FLUORIDE F-18
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateDecember 29, 2023
FDA Product Classification

INGREDIENTS (2)

SODIUM CHLORIDEInactive
Quantity: 9 mg in 1 mL
Code: 451W47IQ8X
Classification: IACT
SODIUM FLUORIDE F-18Active
Quantity: 200 mCi in 1 mL
Code: 9L75099X6R
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Sodium Fluoride - FDA Drug Approval Details